Glenmark Life Sciences Ltd - IPO

Glenmark Life Sciences Ltd IPO Details

Initial public offer of 21,022,222 equity shares of face value of Rs. 2 each (equity shares) of Glenmark Life Sciences Limited (Company or Issuer) for cash at a price of Rs. 720 per equity share (including a share premium of Rs. 718 per equity share) aggregating to Rs. 1513.60 crores (the offer) comprising a fresh issue of 14,722,222 equity shares aggregating to Rs. 1060 crores (the fresh issue) and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited (Promoter Selling Shareholder) and such equity shares, The offered shares) aggregating to Rs. 453.60 crores (The offer for sale). The offer shall constitute 17.16% of the post-offer paid-up equity share capital of the company.The face value of equity shares is Rs. 2 each. Offer Price : Rs. 720 per Equity Share of face value of Rs. 2 each.Anchor Investor offer price: Rs. 720 per Equity share.The Offer Price is 360 times the face value.

Objective of issue

Payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase agreement. Funding capital expenditure requirements. General corporate purposes.

Glenmark Life Sciences Ltd Contact Details

Glenmark Life Sciences Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032

Phone - 91-40-67162222

Fax - 91-40-23001153/23420814

Email - complianceofficer@glenmarklifesciences.com

Website - www.glenmarklifesciences.com